For healthcare professionals in the UK and ROI only
This promotional website has been developed and funded by Boehringer Ingelheim.
The media partners for this activity are GPnotebook and Diabetes on the net. GPnotebook and Diabetes on the net have had no input into the content of this website.
Prescribing information for the United Kingdom and the Republic of Ireland.
Adverse event reporting information can be found at the bottom of the page.
Discover downloadable patient leaflets designed specifically to share with your adult patients to support their education and management of T2D.
Download a leaflet for your adult patients which outlines the purpose of kidney screenings and the importance of returning urine samples. This leaflet was made in collaboration with Sanjay Mistry, an expert through experience who himself was living with diabetes, using patient-friendly language.
Download, print and share this leaflet with your adult patients wishing to observe Ramadan, which outlines key considerations a person with diabetes should be aware of before fasting. This leaflet includes a medication tracker to help patients record any medication changes during this time.
Alia Gilani is a specialist pharmacist whose interests lie in ethnic inequalities, diabetes and cardio-metabolic disease. She helped establish and run a bilingual medication review service in NHS Glasgow called the Minority Ethnic Long-Term (MELT) medicines service, which operated for over a decade and was recognised with awards at the local and national level.
Alia runs outreach clinics for South Asian individuals with diabetes and cardio-metabolic disease in various locations, including mosques and elderly care centres. She was a member of the diabetes working group for the South Asian Health Foundation for 13 years, and is now an appointed trustee of the foundation. She was the first pharmacist to become a member of the Primary Care Diabetes and Obesity Society committee, a position she held for 7 years, and she is currently Vice-Chair of the professional organising committee for Diabetes UK.
CKD: chronic kidney disease; T2D: type 2 diabetes; UACR: urine albumin-creatinine ratio.
Prescribing information for the United Kingdom and the Republic of Ireland.
Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as1:
• monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment
• in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
This promotional website has been developed and funded by Boehringer Ingelheim.
Editorial support for this website has been provided by OmniaMed Communications.
PC-GB-112276 | May 2026
